In this podcast, Spencer H. Durham, PharmD, BCPS, BCIDP; Stefan Gravenstein, MD, MPH; and Barbara Resnick, PhD, CRNP, discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults. Following their dialogue, the faculty field questions from healthcare professionals.Presenters:Spencer H. Durham, PharmD, BCPS, BCIDP Associate Clinical Professor of Pharmacy Practice Director, Alumni & Professional Affairs Clinical Affairs & Outreach Auburn University Harrison School of Pharmacy Auburn, AlabamaStefan Gravenstein, MD, MPHDirectorDivision of Geriatrics and Palliative MedicineThe Warren Alpert Medical School of Brown UniversityProvidence, Rhode IslandBarbara Resnick, PhD, CRNPProfessorSchool of NursingUniversity of MarylandNurse PractitionerRoland Park PlaceBaltimore, MarylandContent based on an online CME program supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP.Link to full program:https://bit.ly/3kvr8ro Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related